Hospital Care

Combating resistant bacteria in hospitals

Hygiene is especially important in medical environments such as hospitals. Hand contact with surfaces contaminated with harmful pathogens is one of the main ways in which germs can spread – resulting in cross-contaminations via “surface to hand” or “hand to hand” contacts. There have been many reports illustrating Triclosan’s potential value in clinical applications (Jones et al. 2000). 
Triclosan has been recommended for the control of methicillin-resistant Staphylococcus aureus (MRSA) infections in hospitals, having been used successfully to control numerous outbreaks at typical use concentrations of 0.3-1% in hand soaps and hand disinfectants (Faoagali et al., 1999; Zafar et al., 1995). In addition to its broad-spectrum antimicrobial and long-lasting efficacy, Triclosan’s anti-inflammatory effect has shown to be an important benefit in reducing the deleterious dermal effects inherent with high-frequency hand washing in industrial and institutional environments.
Several in-vitro and in-vivo methods have been developed to quantify the antimicrobial effectiveness of disinfectants which are commonly used nowadays (Jones et al. 2000). For more information on Triclosan activity in hospital care please contact BASF.


Page functions